Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Feb;127(2):406-11.
doi: 10.1016/j.jaci.2010.11.038.

The Madison Avenue effect: how drug presentation style influences adherence and outcome in patients with asthma

Affiliations
Randomized Controlled Trial

The Madison Avenue effect: how drug presentation style influences adherence and outcome in patients with asthma

Emmanuelle M Clerisme-Beaty et al. J Allergy Clin Immunol. 2011 Feb.

Abstract

Background: Little is known about how drug presentation influences medication adherence.

Objective: To examine the effect of an educational program aimed at increasing expectations of treatment benefit on medication adherence.

Methods: Data are analyzed from 99 participants who underwent electronic drug monitoring during the Trial of Asthma Patient Education, a randomized, placebo-controlled, multicenter trial. Participants with suboptimally controlled asthma were randomized to placebo or montelukast in conjunction with a presentation mode that was either neutral or designed to increase outcome expectancy. Adherence was monitored electronically over 4 weeks and was defined as ≥ 80% use of prescribed doses. Outcome expectancy, peak expiratory flow, prebronchodilator FEV₁, asthma control (Juniper asthma control questionnaire), and asthma-related quality of life were assessed at baseline and at the 4-week follow-up.

Results: Average electronic medication adherence was 69.9%. There was a significant interaction between presentation mode and drug assignment, with participants in the enhanced/montelukast group having a higher change in outcome expectancy (Δ 2.1 points; P < .001) and better medication adherence (odds ratio, 4.0; 95% CI, 1.1-14.3) compared with those in the neutral/placebo group. There was no difference in asthma symptoms, quality of life, or clinical outcomes on the basis of presentation mode. Rather, increased outcome expectancy was associated with modest improvements in asthma symptoms after adjusting for presentation mode, drug assignment, and medication adherence.

Conclusion: The use of an enhanced presentation aimed at increasing outcome expectancy may lead to improved medication adherence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study design
Figure 2
Figure 2
Change in outcome expectancy score over 4-week treatment period.
Figure 3
Figure 3
Mean adherence rate over four weeks by study condition in participants with asthma.

References

    1. Bender BG, Rand C. Medication non-adherence and asthma treatment cost. Curr Opin Allergy Clin Immunol. 2004 Jun;4(3):191–195. - PubMed
    1. Delea TE, Stanford RH, Hagiwara M, Stempel DA. Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*. Curr Med Res Opin. 2008 Dec;24(12):3435–3442. - PubMed
    1. Williams LK, Pladevall M, Xi H, Peterson EL, Joseph C, Lafata JE, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004 Dec;114(6):1288–1293. - PubMed
    1. Conn KM, Halterman JS, Lynch K, Cabana MD. The impact of parents’ medication beliefs on asthma management. Pediatrics. 2007 Sep;120(3):e521–6. - PMC - PubMed
    1. Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999 Dec;47(6):555–567. - PubMed

Publication types